Complications of Therapy and a Diagnostic Dilemma Case
- 15 December 2003
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (24) , 4651-4653
- https://doi.org/10.1200/jco.2003.04.169
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibodyJournal of the American Academy of Dermatology, 2002
- Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor InhibitionJournal of Clinical Oncology, 2002
- Follicular Toxic Effects of Chimeric Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Used to Treat Human Solid TumorsArchives of Dermatology, 2002
- Epidermal growth factor receptor biology (IMC-C225)Current Opinion in Oncology, 2001
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal Of Cancer, 2001
- Contributions of the epidermal growth factor receptor to keratinocyte motilityMicroscopy Research and Technique, 1998